The eye disease called age-related macular degeneration is expected to affect 18 million people worldwide by 2040. The dry form is currently untreatable but a slew of promising therapies could offer ways to lessen the damage.
The eye disease called age-related macular degeneration is expected to affect 18 million people worldwide by 2040. The dry form is currently untreatable but a slew of promising therapies could offer ways to lessen the damage.
doi: https://doi.org/10.1038/d41586-021-03576-2
This article is part of Nature Outline: Age-related macular degeneration, an editorially independent supplement produced with the financial support of third parties. About this content.